Close up hands of senior elderly woman patient suffering from pakinsons desease...
Close up hands of senior elderly woman patient suffering from pakinson's desease symptom.

Image source: Adobe Stock/ipopba 

News • Parkinson disease detection

Low-cost sensor detects early-stage Parkinson's disease in biological samples

Researchers at the University of Campinas (UNICAMP) and the Federal University of São Carlos (UFSCar) in Brazil have developed an electrochemical sensor that detects Parkinson's disease at different stages.

The device was fabricated using an ordinary 3D printer and proved capable of early diagnosis, also serving as a model for the identification of other diseases, according to an article published in the journal Sensors and Actuators B: Chemical.

"The sensor rapidly indicates the level of the protein PARK7/DJ-1 in human blood and synthetic cerebrospinal fluid. The molecule is associated with Parkinson's at levels below 40 micrograms per liter [40 μg/L]," said Cristiane Kalinke, first author of the article. Kalinke is a postdoctoral fellow at UNICAMP's Institute of Chemistry (IQ) and a visiting researcher at Manchester Metropolitan University in the United Kingdom. "It can be printed in various shapes and sizes. It can also be miniaturized to create a genuinely portable device that requires a very small sample," she explained.

The device, produced by ordinary 3D printing and capable of being miniaturized,...
The device, produced by ordinary 3D printing and capable of being miniaturized, detects levels of the protein PARK7/DJ-1, which is associated with Parkinson's disease.

Image source: Cristiane Kalinke and Paulo Roberto de Oliveira 

To build the sensor, the researchers used a commercial filament made basically of polylactic acid (PLA), a biodegradable polymer, associated with a conductive material (graphene) and other additives. Three electrodes printed on the plastic substrate by additive manufacturing were chemically treated to make them more conductive and stimulate formation of a surface layer of functional groups (carboxyls) that bind to antibodies.

The activation process entailed removal of the polymeric insulating surface from the electrodes by immersion in sodium hydroxide (NaOH) and application of an electric potential (positive and negative). A reaction was then promoted between antibodies and PARK7/DJ-1 to produce a diagnosis.

Specific antibodies for PARK7/DJ-1 were immobilized on the surface of the electrodes, and the sensor was used to detect the protein at three levels: 30 μg/L, 40 μg/L and 100 μg/L. The average level in patients diagnosed with Parkinson's at different stages is approximately 30 ± 9 μg/L, according to data in the scientific literature.

"Patients are highly unlikely to go to see a doctor for a routine exam to detect early-stage Parkinson's. If onset of the disease is suspected, physical and behavioral symptoms have probably appeared, and the disease is probably already well-established," said Juliano Alves Bonacin, last author of the article and a professor in the Department of Inorganic Chemistry at IQ-UNICAMP.

"We decided to design and produce a very simple device that was cheap and could be used for continual monitoring, with alerts for physicians and patients if there were alterations in the level of PARK7/DJ-1, which is especially useful when analyzed in conjunction with other biomarkers."

Imagine there's an outbreak of a certain disease in a particular area. With a few 3D printers and some electrodes, it would be possible to produce a sensor like ours on site

Juliano Alves Bonacin

The study's primary significance is as proof of concept insofar as it demonstrated the versatility of 3D printing in producing a platform for the immobilization of biomolecules. "We succeeded in 3D printing all components of an electrochemical cell using only a polymer as the conductive material," Kalinke said. "In this specific study, commercially available materials were purchased off the shelf, but we're developing novel filaments for 3D printing in our lab as well."

According to the authors, the platform could be used to diagnose other diseases. In the specific case of PARK7/DJ-1, the protein is associated with type 2 diabetes, infertility and some cancers, as well as neurological disorders. The aim is to extend its use to other biomarkers, and Kalinke is working on a sensor to diagnose yellow fever.

"Imagine there's an outbreak of a certain disease in a particular area. With a few 3D printers and some electrodes, it would be possible to produce a sensor like ours on site," Bonacin said.


Source: São Paulo Research Foundation (FAPESP) 

14.04.2023

Related articles

Photo

News • Opening the blood-brain barrier

3D-printed acoustic holograms against Alzheimer's or Parkinson's

A research team in Spain and the US has created 3D-printed acoustic holograms to improve the treatment of diseases like Alzheimer's and Parkinson's, among others.

Photo

News •

‘Mini-Brains’: Evidence of Zika’s toll on fetal cortex

Studying a new type of pinhead-size, lab-grown brain made with technology first suggested by three high school students, Johns Hopkins researchers have confirmed a key way in which Zika virus causes…

Photo

Article • Research

3D printers help neuroradiologists

The treatment of cerebral aneurysms is often very complex and initially it is not always obvious which type of treatment is best suited for an individual case. In October, during the Annual Congress…

Related products

Subscribe to Newsletter